Deka Bank Deutsche Girozentrale Intellia Therapeutics, Inc. Transaction History
Deka Bank Deutsche Girozentrale
- $54.1 Billion
- Q4 2024
A detailed history of Deka Bank Deutsche Girozentrale transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 75,000 shares of NTLA stock, worth $689,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,000
Previous 75,000
-0.0%
Holding current value
$689,250
Previous $1.54 Million
44.05%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding NTLA
# of Institutions
336Shares Held
96.1MCall Options Held
1.06MPut Options Held
863K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$115 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$93.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$88.2 Million0.0% of portfolio
-
State Street Corp Boston, MA5.21MShares$47.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.81MShares$35.1 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $699M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...